Merit Medical Systems EBITDA Margin 2010-2023 | MMSI
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Merit Medical Systems (MMSI) over the last 10 years. The current EBITDA margin for Merit Medical Systems as of December 31, 2023 is .
| Merit Medical Systems EBITDA Margin Historical Data |
| Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
| 2023-12-31 |
$1.26B |
$0.23B |
18.04% |
| 2023-09-30 |
$1.23B |
$0.22B |
17.94% |
| 2023-06-30 |
$1.20B |
$0.20B |
16.69% |
| 2023-03-31 |
$1.17B |
$0.19B |
16.37% |
| 2022-12-31 |
$1.15B |
$0.18B |
15.65% |
| 2022-09-30 |
$1.14B |
$0.17B |
15.15% |
| 2022-06-30 |
$1.12B |
$0.17B |
15.25% |
| 2022-03-31 |
$1.10B |
$0.16B |
14.27% |
| 2021-12-31 |
$1.07B |
$0.16B |
14.71% |
| 2021-09-30 |
$1.05B |
$0.16B |
14.71% |
| 2021-06-30 |
$1.03B |
$0.14B |
13.77% |
| 2021-03-31 |
$0.97B |
$0.12B |
12.07% |
| 2020-12-31 |
$0.96B |
$0.11B |
11.00% |
| 2020-09-30 |
$0.96B |
$0.09B |
8.92% |
| 2020-06-30 |
$0.96B |
$0.08B |
8.62% |
| 2020-03-31 |
$1.00B |
$0.11B |
11.29% |
| 2019-12-31 |
$1.00B |
$0.12B |
12.06% |
| 2019-09-30 |
$0.97B |
$0.13B |
13.40% |
| 2019-06-30 |
$0.95B |
$0.15B |
15.28% |
| 2019-03-31 |
$0.92B |
$0.14B |
15.25% |
| 2018-12-31 |
$0.88B |
$0.13B |
14.61% |
| 2018-09-30 |
$0.84B |
$0.12B |
14.74% |
| 2018-06-30 |
$0.80B |
$0.10B |
12.53% |
| 2018-03-31 |
$0.76B |
$0.09B |
12.24% |
| 2017-12-31 |
$0.73B |
$0.09B |
11.95% |
| 2017-09-30 |
$0.70B |
$0.08B |
12.09% |
| 2017-06-30 |
$0.67B |
$0.08B |
12.48% |
| 2017-03-31 |
$0.64B |
$0.08B |
12.56% |
| 2016-12-31 |
$0.60B |
$0.08B |
13.25% |
| 2016-09-30 |
$0.58B |
$0.07B |
12.50% |
| 2016-06-30 |
$0.56B |
$0.08B |
13.50% |
| 2016-03-31 |
$0.55B |
$0.08B |
13.82% |
| 2015-12-31 |
$0.54B |
$0.08B |
14.02% |
| 2015-09-30 |
$0.54B |
$0.08B |
15.27% |
| 2015-06-30 |
$0.53B |
$0.09B |
16.04% |
| 2015-03-31 |
$0.52B |
$0.08B |
15.16% |
| 2014-12-31 |
$0.51B |
$0.08B |
14.90% |
| 2014-09-30 |
$0.50B |
$0.07B |
14.49% |
| 2014-06-30 |
$0.48B |
$0.07B |
14.08% |
| 2014-03-31 |
$0.46B |
$0.07B |
14.44% |
| 2013-12-31 |
$0.45B |
$0.06B |
13.81% |
| 2013-09-30 |
$0.43B |
$0.05B |
12.06% |
| 2013-06-30 |
$0.41B |
$0.05B |
12.14% |
| 2013-03-31 |
$0.40B |
$0.05B |
12.16% |
| 2012-12-31 |
$0.40B |
$0.05B |
13.16% |
| 2012-09-30 |
$0.38B |
$0.05B |
13.80% |
| 2012-06-30 |
$0.38B |
$0.05B |
12.96% |
| 2012-03-31 |
$0.37B |
$0.05B |
13.59% |
| 2011-12-31 |
$0.36B |
$0.05B |
14.48% |
| 2011-09-30 |
$0.35B |
$0.05B |
14.61% |
| 2011-06-30 |
$0.33B |
$0.04B |
12.05% |
| 2011-03-31 |
$0.32B |
$0.04B |
11.71% |
| 2010-12-31 |
$0.30B |
$0.03B |
10.81% |
| 2010-09-30 |
$0.28B |
$0.03B |
11.70% |
| 2010-06-30 |
$0.28B |
$0.05B |
16.30% |
| 2010-03-31 |
$0.27B |
$0.05B |
16.92% |
| 2009-12-31 |
$0.26B |
$0.05B |
17.90% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$4.299B |
$1.257B |
|
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
|
